Literature DB >> 23541294

Endoscopic intranasal surgery for congenital nasolacrimal duct obstruction--a new approach.

Hakan Korkmaz1, Mukadder Korkmaz, Refika Hande Karakahya, Mahmut Serhatlı.   

Abstract

OBJECTIVE: Congenital nasolacrimal duct obstruction can be treated with a spectrum of techniques, starting with conservative massage to more invasive dacryocystorhinostomy. There has been controversy regarding the optimal treatment procedure. We introduced a unique technique to treat congenital nasolacrimal duct obstruction and analyzed its success rate and complications.
METHODS: In a retrospective study, we introduced the results of our technique. This technique consisted of endoscope guided inspection of the Hasner valve area, trial of irrigation, incision of the imperforate Hasner valve and irrigation again. If these maneuvers were not effective, more invasive procedure, probing under endoscopic control was done.
RESULTS: 48 children (55 eyes) were included in the study. Complete improvement was achieved in 51/55 eyes (92.72% success rate). We did not encounter any early or late complication.
CONCLUSIONS: The great majority of the congenital nasolacrimal duct obstruction stem from Hasner valve area pathologies. The endoscopic intervention of this area is very effective and safe way of treatment. This technique should be added to the armamentarium of the congenital nasolacrimal duct obstruction treatment.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541294     DOI: 10.1016/j.ijporl.2013.03.005

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

Review 1.  Insights in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Elena Avram
Journal:  Rom J Ophthalmol       Date:  2017 Apr-Jun

2.  Lacrimal Drainage System Obstruction Following Inferior Turbinate Surgery.

Authors:  Hirohiko Tachino; Hiromasa Takakura; Hideo Shojaku; Michiro Fujisaka; Chiharu Fuchizawa; Atsushi Hayashi
Journal:  Front Surg       Date:  2020-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.